The SLC12A1 gene helps the kidneys reclaim salt from urine, which supports fluid balance, blood pressure, and the body’s ability to make concentrated urine. This gene plays an important role in moving sodium, potassium, and chloride in a part of the kidney called the loop of Henle. If it does not work properly, the kidneys can lose too much salt and water, leading to frequent urination, dehydration, low potassium, and poor growth. Pathogenic variants in the SLC12A1 gene cause a form of Bartter syndrome, often starting before or soon after birth.
What is a gene?
Genes are stretches of DNA that hold instructions cells use to make molecules or regulate activities in the body. Some provide the directions for building proteins, which are the parts of cells that do much of the work. Others mainly help control when a process happens, where it happens, and how active it is. Together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, and medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
SLC12A1Gene function
What if the gene works
The SLC12A1 gene helps kidney tubules reabsorb sodium, potassium, and chloride from fluid in the kidneys. This supports fluid balance, normal blood pressure, and your body’s ability to concentrate urine.
Risk
What if the gene does not work
Variants in the SLC12A1 gene can cause Bartter syndrome type 1, a kidney salt-wasting condition that often starts before or soon after birth. Milder or more severe variants can change when symptoms begin and how strongly salt, potassium, and calcium balance is affected.
Treatment
What does that mean for your treatment
Pathogenic variants in the SLC12A1 gene can support treatment aimed at replacing ongoing salt and potassium losses, and many people also benefit from nonsteroidal anti-inflammatory drugs such as indomethacin to reduce kidney salt wasting. Loop diuretics are generally avoided because they block the same kidney transporter that is already underactive.
Conditions associated with SLC12A1
Gene function
What if the gene works
In the kidney, the SLC12A1 gene helps move key salts from forming urine back into the body. This is a central step in how your kidneys concentrate urine and keep fluid levels steady. Its protein works in a kidney segment that fine tunes salt, water, and mineral handling.
Inside kidney tubules, the SLC12A1 gene helps move sodium, potassium, and chloride out of forming urine and back toward the bloodstream. This steady salt reabsorption supports normal fluid balance throughout the body.
By reclaiming salt in the loop of Henle, this gene helps build the kidney’s salt gradient, a difference in salt levels that helps control water movement. That process lets your kidneys make urine more concentrated when your body needs to save water.
The movement of these salts also creates the right electrical conditions in the kidney tubule for calcium and magnesium to be reabsorbed. This helps your body hold on to important minerals while urine is being formed.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, such as variation in appearance, metabolism, or the body’s response to environmental influences. Many have no noticeable effect at all and simply reflect naturally occurring genetic variation. In some situations, though, a variant can change gene function more markedly and may play a role in or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC12A1 gene can change how the kidney’s salt transporter is built, folded, or moved to the cell surface, which may reduce or stop sodium, potassium, and chloride transport. Some SLC12A1 gene variants leave a little transporter activity, while more disruptive variants can create a shortened protein or prevent it from working at all. This range helps explain how SLC12A1 variants affect kidney salt handling and why Bartter syndrome type 1 may appear earlier or be more marked in some people than in others.
How variants are linked to conditions
Pathogenic variants in the SLC12A1 gene cause Bartter syndrome type 1, an inherited kidney condition that often starts before birth or in early infancy. People with Bartter syndrome caused by variants in the SLC12A1 gene often have too much amniotic fluid during pregnancy, then develop dehydration, frequent urination, low potassium, and slower growth after birth. This is a confirmed genetic diagnosis, not just a general risk finding.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely present in the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SLC12A1, risk is mainly shaped by inherited gene changes rather than lifestyle. A child is most likely to be born with this condition when both biological parents carry a harmful SLC12A1 change, and the chance can be higher in families where parents are blood relatives, such as cousins.
Inheritance of SLC12A1 variants
Variants in the SLC12A1 gene are inherited in an autosomal recessive pattern, which is the usual SLC12A1 inheritance pattern for Bartter syndrome type 1. This means a child must inherit one changed copy from each parent to have the condition. If both parents carry one SLC12A1 gene variant, each pregnancy has a 25% chance of producing a child with the condition, a 50% chance of producing a child who is a carrier, and a 25% chance of producing a child who inherits neither variant. Boys and girls are affected equally.
What does my SLC12A1 result mean for my family?
SLC12A1 results linked to Bartter syndrome are usually passed down in a recessive pattern, which means close relatives may also be carriers even if they have no symptoms. Brothers and sisters could also have the condition or be carriers, depending on the variants in the family. For parents, this kind of result often means each carries one changed copy of the SLC12A1 gene.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the SLC12A1 gene, doctors use SLC12A1 genetic testing on a blood or saliva sample. The lab reads the gene’s DNA code and compares it with the usual sequence to look for variants. Results can show whether a variant is present, absent, or unclear.
When should I consider getting a genetic test?
Genetic testing for the SLC12A1 gene may be worth considering if a baby or child has signs of Bartter syndrome, such as poor growth, dehydration, frequent urination, or ongoing low potassium and salt loss. It can also help when this condition runs in the family or when prenatal findings suggest it.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how informative it is depends on the condition and on the kind of variant found. Over time, many factors shape how the body functions, including lifestyle, environment, age, and medical history. For some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and is best interpreted alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small inherited differences can change how the body absorbs, breaks down, transports, or responds to a drug, so the same treatment may work better for one person than for another. This is common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences can affect a person’s response to medication. It examines relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the SLC12A1 gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in guiding routine medication choices, so general health or medicine concerns are best discussed with your doctor. SLC12A1 has been studied because it helps the kidneys handle salt and is linked to how loop diuretics work, but this research is not used as standard prescribing guidance.
History
Bartter syndrome was first described in 1962, years before doctors knew which genes were involved. In the 1990s, inheritance patterns and kidney findings helped narrow the search for the underlying cause. Building on this early work, scientists identified variants in the SLC12A1 gene as a cause of antenatal Bartter syndrome type 1, linking a long-recognized clinical pattern to a specific gene. This was part of a broader shift in medicine, when kidney conditions once defined only by symptoms began to be classified by their genetic basis. Over time, descriptions became more precise, and the SLC12A1 gene became an established part of the genetic diagnosis of this condition.